KRAS and neoplasm: IGF2BP1 has been reported to have several target RNAs that encode proteins with key roles in tumor transformation and development, such as IGF2, ACTB, CNOT1, GLI1, CD44, MYC, MAPK4, MDR1, KRAS, and β-catenin [40].